N/A
Completed N=23,026
Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and Safety
Source: ClinicalTrials.gov NCT05110014 ↗Enrolled (actual)
23,026
Serious AEs
—
Results posted
Apr 2022
Primary outcomePrimary: Number of Participants Screening Positive for Depression, Fall Risk or Intimate Partner Violence - Pre mPATH Use — 224; 94; 55; 165 Participants
Summary
This is a sub-study for data analysis of data collected as part of the larger randomized controlled trial "Effectiveness and Implementation of mPATH-CRC" (NCT03843957) to determine if self-administered screening with an iPad increases the detection of patients with depression, falls, and intimate partner violence.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Screening Positive for Depression, Fall Risk or Intimate Partner Violence - Pre mPATH Use |
224; 94; 55; 165; 265; 264 | — |
| PRIMARY Number of Participants Screening Positive for Depression, Fall Risk or Intimate Partner Violence - Post mPATH Use |
509; 463; 235; 242; 418; 235 | — |
| SECONDARY Number of Participants Screening Positive for Depression Using Patient Health Questionnaires (PHQ-2 Score of 3 or Greater) |
188; 450 | — |
| SECONDARY Number of Participants Screening Positive for Moderately Severe or Severe Depression Using Patient Health Questionnaires (PHQ-9 Score Greater Than 14) |
82; 206 | — |
| SECONDARY Number of Participants Screening Positive for Severe Depression Using Patient Health Questionnaires (PHQ-9 Score Greater Than 19) |
28; 86 | — |
| SECONDARY Number of Participants With a Patient Health Questionnaires (PHQ-9 Score Greater Than 14) and Not Currently Taking a Medication for Depression. |
63; 139 | — |
| SECONDARY Number of Participants Who Report Thoughts of Self Harm - Patient Health Questionnaire (PHQ-9) in All Practices |
39; 116 | — |
| SECONDARY Number of Participants Screening Positive for Fall Risk at Home in All Practices |
907; 1692 | — |
| SECONDARY Number of Participants Screening Positive for Intimate Partner Violence in All Practices |
10; 310 | — |
Eligibility Criteria
Inclusion Criteria
- Age 18 or older
- Completed a provider visit at the study clinic during the 60 days prior to the clinic launching the mPATH program (the "pre" time period), or completed a provider visit at the study clinic during days 14 - 73 after the launch of mPATH (the "post" time period)
- Have a preferred language of English or Spanish
Exclusion Criteria
- Requiring a language interpreter for a language other than Spanish
Data sourced from ClinicalTrials.gov (NCT05110014). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.